← Every applicant
Tp Anda Holdings FDA Approvals
9 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| SAPROPTERIN DIHYDROCHLORIDENew drugSep 3, 2025FOR SOLUTION, ORAL |
| PREDNISOLONENew drugJun 23, 2025SOLUTION, ORAL |
| NITROGLYCERINNew drugNov 29, 2024OINTMENT, INTRA-ANAL |
| DAPSONENew drugAug 26, 2024GEL, TOPICAL |
| DAPSONENew drugJun 6, 2023GEL, TOPICAL |
| NAPROXENNew drugMay 31, 2023TABLET, DELAYED RELEASE, ORAL |
| APOMORPHINE HYDROCHLORIDENew drugFeb 23, 2022INJECTABLE, SUBCUTANEOUS |
| BETAMETHASONE DIPROPIONATENew drugFeb 18, 2022OINTMENT, TOPICAL |
| FLUOCINOLONE ACETONIDENew drugFeb 5, 2021OIL/DROPS, OTIC |